Colorectal Cancer

>

Latest News

Invikafusp Alfa Shows Potential in PD-1 Refractory Solid Tumors
Invikafusp Alfa Shows Potential in PD-1 Refractory Solid Tumors

November 21st 2024

Invikafusp alfa showed promise as a treatment option across a range of high tumor mutational burden cancers or virally associated malignancies.

FDA Clears Phase 2 Trial of Leronlimab for Microsatellite-Stable CRC
FDA Clears Phase 2 Trial of Leronlimab for Microsatellite-Stable CRC

November 6th 2024

FDA Approves Cologuard Plus Stool DNA Test for Colorectal Cancer Screening
FDA Approves Cologuard Plus Stool DNA Test for Colorectal Cancer Screening

October 4th 2024

Assessing Targeted PET Imaging for Advanced Rectal Cancer
Assessing Targeted PET Imaging for Advanced Rectal Cancer

October 3rd 2024

No Survival Advantage Seen With Ramucirumab and TAS-102 in Metastatic Colorectal Cancer
No Survival Advantage Seen With Ramucirumab and TAS-102 in Metastatic Colorectal Cancer

September 15th 2024

Latest CME Events & Activities

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

Differentiating Adverse Events for Antibody-Drug Conjugates Across Solid Tumor Management

View More

<1
...
2930313233